Other necrotizing vasculopathies (FG)

NECROVASC_FG

vasculitis: Vasculitis represents a clinically heterogenous group of diseases of multifactorial etiology characterized by inflammation of either large-sized vessels (large-vessel vasculitis, e.g. Giant-cell arteritis and Takayasu arteritis; see these terms), medium-sized vessels (medium-vessel vasculitis e.g. polyarteritis nodosa and Kawasaki disease; see these terms), or small-sized vessels (small-vessel vasculitis, e.g. granulomatosis with polyangiitis, microscopic polyangiitis, immunoglobulin A vasculitis, and cutaneous leukocytoclastic angiitis; see these terms). Vasculitis occurs at any age, may be acute or chronic, and manifests with general symptoms such as fever, weight loss and fatigue, as well as more specific clinical signs depending on the type of vessels and organs affected. The degree of severity is variable, ranging from life or sight threatening disease (e.g. BehC'et disease, see this term) to relatively minor skin disease.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints M13_WEGENER M13_TAKAYASU GIANT_CELL_TEMP_ARTERITIS M13_MICROPOLYANG M13_NECROVASCNAS	2310
6. Filter based on genotype QC (FinnGen only)	2310

Control definitions (FinnGen only)

Control exclude: RHEUMA_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	NECROVASC_FG
CONTROL_EXCLUDE	RHEUMA_ENDPOINTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_WEGENER\|M13_TAKAYASU\|GIANT_CELL_TEMP_ARTERITIS\|M13_MICROPOLYANG\|M13_NECROVASCNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other necrotizing vasculopathies (FG) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13908	8486	5320
Only index persons	11799	7333	4466
Unadjusted period prevalence (%)
Whole population	0.21	0.24	0.15
Only index persons	0.23	0.27	0.17
Median age at first event (years)
Whole population	68.50	69.79	66.41
Only index persons	68.01	69.21	66.04

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2310	1345	965
Unadjusted period prevalence (%)	0.44	0.46	0.43
Median age at first event (years)	65.41	64.89	66.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2047: Matched controls
20471

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AX01

ATC

azathioprine; systemic

30.1

323.0

487

210

H02AB06

ATC

prednisolone; systemic

14.1

323.0

1738

5843

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

7.7

323.0

1396

4479

M35.3

ICD-10 Finland

Polymyalgia rheumatica

57.0

323.0

476

108

M31.3

ICD-10 Finland

Wegener granulomatosis

+∞

323.0

439

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

48.5

323.0

577

164

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

4025.3

323.0

1108

PAW37

NOMESCO Finland

Biopsy of temporal artery

478.0

323.0

500

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

70.1

323.0

850

205

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

52.8

307.4

369

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

+∞

271.0

254

M05BA04

ATC

alendronic acid; oral

8.5

245.8

606

970

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

201.8

1311

6084

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

10.3

200.0

422

501

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

193.9

183

M17.1

ICD-10 Finland

Other primary gonarthrosis

12.0

187.9

363

360

A02BC02

ATC

pantoprazole; systemic

4.2

175.4

1620

9674

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

24.4

171.5

248

115

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

352.4

164.6

164

M31.6

ICD-10 Finland

Other giant cell arteritis

559.9

159.1

156

P01BA02

ATC

hydroxychloroquine; oral

18.4

154.6

246

151

L04AA06

ATC

mycophenolic acid; systemic

33.6

152.2

201

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

152.0

144

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

+∞

152.0

144

M13.9

ICD-10 Finland

Arthritis, unspecified

19.7

151.0

234

133

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

20.9

150.2

228

122

L88

ICPC

Rheumatoid/seropositive arthritis

68.5

147.8

170

M31.7

ICD-10 Finland

Microscopic polyangiitis

+∞

138.1

131

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

69.7

129.9

149

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

234.9

129.5

132

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

127.4

121

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

30.7

127.4

172

R50.9

ICD-10 Finland

Fever, unspecified

4.6

124.0

503

1367

I77.6

ICD-10 Finland

Arteritis, unspecified

309.0

115.3

116

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

6.7

115.0

315

537

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

9.0

111.8

250

312

H02AB07

ATC

prednisone; oral

4.2

111.8

492

1430

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.6

110.0

433

1127

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

108.3

103

M16.1

ICD-10 Finland

Other primary coxarthrosis

18.8

107.1

168

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

101.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

95.0

447

1359

L01AA01

ATC

cyclophosphamide; systemic

70.4

93.5

107

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.0

92.0

700

3048

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

55.8

89.3

106

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.1

89.0

196

236

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.6

88.1

243

412

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

7.0

87.8

230

363

M31.1

ICD-10 Finland

Thrombotic microangiopathy

884.8

87.3

ZX120

NOMESCO Finland

Intravenous

4.2

82.9

355

980

R51.80

ICD-10 Finland

Headache

3.6

80.2

414

1342

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

7.7

79.6

194

274

C03CA01

ATC

furosemide; systemic

2.6

78.4

801

4081

A07EC01

ATC

sulfasalazine; oral, rectal

10.8

77.0

153

152

H02AB04

ATC

methylprednisolone; systemic

3.4

76.9

427

1459

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

11.8

76.0

144

130

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

75.6

587

2530

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

30.8

74.6

100

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

64.0

74.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

11.0

73.2

144

140

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.4

70.6

849

4651

L04AA13

ATC

leflunomide; oral

97.3

68.4

TGC00

NOMESCO Finland

Bronchial lavation

9.0

68.2

150

179

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

19.9

68.1

104

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

+∞

67.0

N02AX02

ATC

tramadol; systemic, rectal

2.3

66.4

890

5102

NF1AA

NOMESCO Finland

Hip X-ray examination

5.3

65.6

213

437

DHA10

NOMESCO Finland

Biopsy of cavity of nose

19.0

63.3

J01DB01

ATC

cefalexin; oral

2.5

60.8

1658

12994

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

+∞

60.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

4.5

59.8

226

544

J01MA12

ATC

levofloxacin; systemic

2.7

59.3

481

2084

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

63.9

58.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.5

57.8

301

963

4476A

ICD-9 Finland

Other disorders of arteries and arterioles, Arteritis, unspecified

+∞

57.6

N02BE01

ATC

paracetamol; systemic, rectal

2.6

57.4

1758

14336

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

37.8

57.3

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

125.7

57.1

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

125.7

57.1

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

56.5

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.8

56.1

262

766

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

55.4

445

1906

TPX00

NOMESCO Finland

Biopsy of artery or vein

195.3

55.2

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.5

53.0

143

232

A11CC03

ATC

alfacalcidol; systemic

8.1

52.0

121

158

J01FF01

ATC

clindamycin; systemic

2.3

51.6

605

3157

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

16.6

51.2

M05BA07

ATC

risedronic acid; oral

5.8

51.0

152

280

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.5

50.7

262

829

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

50.5

675

3738

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.3

49.3

194

484

A02BC01

ATC

omeprazole; systemic

2.2

49.1

644

3523

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

489.0

48.6

N03AX16

ATC

pregabalin; oral

2.4

48.4

510

2512

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.1

48.1

202

535

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.2

47.9

195

502

M10.9

ICD-10 Finland

Gout, unspecified

6.3

47.1

131

221

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

47.1

M25.5

ICD-10 Finland

Pain in joint

2.3

45.7

515

2609

M31.0

ICD-10 Finland

Hypersensitivity angiitis

457.5

45.4

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.4

45.4

237

753

AA1AD

NOMESCO Finland

CT of head and brain

2.2

43.8

592

3250

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

43.4

863

5541

1XC02

NOMESCO Finland

20.3

43.3

N18.8

ICD-10 Finland

Other chronic renal failure

6.3

43.2

119

198

J01CA04

ATC

amoxicillin; systemic

2.0

42.8

1566

12576

TK800

NOMESCO Finland

Hemodialysis

7.0

42.5

108

161

M79.6

ICD-10 Finland

Pain in limb

2.0

42.3

701

4183

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.2

42.0

171

439

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

42.0

687

4076

Z94.0

ICD-10 Finland

Kidney transplant status

15.1

41.8

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

41.0

41.7

R06.0

ICD-10 Finland

Dyspnoea

2.1

41.2

559

3063

A46

ICD-10 Finland

Erysipelas

2.6

40.9

331

1401

Z49.1

ICD-10 Finland

Extracorporeal dialysis

10.0

40.8

H04.10

ICD-10 Finland

Dry eye syndrome

3.0

40.6

254

916

C08CA01

ATC

amlodipine; oral

1.9

40.4

829

5345

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

39.9

988

6802

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

25.0

39.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

39.7

216

705

N18.0

ICD-10 Finland

End-stage renal disease

12.9

39.6

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.8

39.3

137

301

H26.3

ICD-10 Finland

Drug-induced cataract

31.3

39.3

J01MA02

ATC

ciprofloxacin; systemic

1.9

38.7

819

5310

A12AA04

ATC

calcium carbonate; oral

8.7

38.7

101

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.3

38.4

105

173

J01MA14

ATC

moxifloxacin; systemic

2.9

38.2

250

928

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

38.1

271

1059

M04AA01

ATC

allopurinol; systemic

2.8

37.8

270

1059

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

37.7

391

1881

ZXA00

NOMESCO Finland

Right side

2.0

37.3

579

3330

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

36.9

237

866

B03XA02

ATC

darbepoetin alfa; parenteral

7.5

36.4

122

B01AB05

ATC

enoxaparin; parenteral

2.0

36.0

571

3302

N03AX12

ATC

gabapentin; oral

2.5

35.8

312

1369

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.7

35.2

274

1126

S18

ICPC

Laceration/cut

1.8

35.1

837

5605

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.7

34.8

263

1064

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

125.5

34.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.0

34.8

221

801

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

34.4

492

2720

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

6.0

33.9

166

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

33.9

406

2078

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

33.5

379

1891

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

33.4

WX110

NOMESCO Finland

Local anesthesy

1.8

33.2

1277

9899

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.5

33.2

167

513

J01AA02

ATC

doxycycline; systemic

1.9

33.1

1543

12729

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

11.2

33.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

32.9

884

6115

ZX108

NOMESCO Finland

Inhalation

18.0

32.8

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

22.9

32.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

32.5

268

1138

44698

ICD-8 Finland

Polyarteritis nodosa and allied conditions, Other

+∞

32.4

GD1AD

NOMESCO Finland

Thorax CT examination

3.9

32.3

137

365

N08.5*M31.1

ICD-10 Finland

Glomerular disorders in thrombotic thrombocytopenic purpura

321.8

31.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

31.9

169

540

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.8

31.8

139

380

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

12.8

31.3

R03AC02

ATC

salbutamol; inhalant

1.7

31.3

983

7102

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

31.1

451

2492

C07AB07

ATC

bisoprolol; oral

1.7

31.0

1024

7503

WX002

NOMESCO Finland

Sedation and analgesia

2.1

30.9

407

2162

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

30.8

728

4803

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

162.4

30.7

WW400

NOMESCO Finland

Plasmaferesis

111.7

30.7

TDM10

NOMESCO Finland

Puncture of maxillary antrum

4.4

30.7

114

268

M30.0

ICD-10 Finland

Polyarteritis nodosa

47.0

30.6

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

14.9

30.6

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

30.3

ZXA05

NOMESCO Finland

Left side

1.9

30.0

526

3124

WX320

NOMESCO Finland

Spinalanesthesy

2.1

29.9

383

2010

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.9

29.6

194

717

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

+∞

29.2

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

29.2

376

1976

L17

ICPC

Foot/toe symptom/complaint

1.9

29.1

508

3006

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

14.3

28.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

28.9

176

620

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

28.9

709

4708

L04AD01

ATC

ciclosporin; systemic

8.0

28.8

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.6

28.7

224

919

UJF32

NOMESCO Finland

Coloscopy

1.9

28.6

550

3368

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

13.9

28.6

A02BC03

ATC

lansoprazole; oral

1.8

28.5

612

3888

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

28.2

XX9XE

NOMESCO Finland

Other ultrasound examination

39.6

28.1

TNG10

NOMESCO Finland

Puncture of knee

64.9

28.0

R53

ICD-10 Finland

Malaise and fatigue

2.0

27.6

435

2472

J01FA06

ATC

roxithromycin; oral

1.7

27.5

794

5520

NF1DA

NOMESCO Finland

X-ray of hips

17.5

27.5

ZXA10

NOMESCO Finland

Bilateral

2.0

27.4

419

2353

212

Kela drug reimbursment

Gout

+∞

27.1

137

Kela drug reimbursment

Uraemia requiring dialysis

12.9

27.1

L28

ICPC

Limited function/disability (L)

2.1

27.1

338

1748

XG410

NOMESCO Finland

Flow-volume spirometry

3.8

27.0

120

333

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.2

26.8

169

127

Kela drug reimbursment

Transplant complication

8.0

26.7

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

98.0

26.7

1AA01

NOMESCO Finland

141.8

26.7

SPAT1153

SPAT

Removal of sutures

1.8

26.5

625

4073

A02BC05

ATC

esomeprazole; systemic

1.7

26.5

770

5345

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

46.4

26.5

N01

ICPC

Headache

2.7

26.4

191

749

N02AA05

ATC

oxycodone; systemic

2.2

26.4

306

1528

NH3EA

NOMESCO Finland

Feet X-ray examination with load

11.4

26.1

WX111

NOMESCO Finland

Local infiltration anesthesia

60.8

26.0

L04AA01

ATC

[U] ciclosporin; systemic

10.0

26.0

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.7

25.5

188

743

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

25.4

386

2155

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

25.4

291

1445

G44.2

ICD-10 Finland

Tension-type headache

2.3

25.4

257

1205

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

6.5

25.1

104

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.8

25.1

167

622

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

25.0

N085, M318

ICD-10 Finland

+∞

25.0

S97

ICPC

Chronic ulcer skin

3.2

25.0

136

442

Z49.0

ICD-10 Finland

Preparatory care for dialysis

10.0

25.0

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

17.3

24.9

J31.0

ICD-10 Finland

Chronic rhinitis

2.8

24.9

173

660

H02AB09

ATC

hydrocortisone; systemic

5.4

24.8

146

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

24.7

230

1033

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

91.2

24.7

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

131.6

24.6

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

131.6

24.6

M79.7

ICD-10 Finland

Fibromyalgia

7.7

24.4

NG1DA

NOMESCO Finland

X-ray of knees

20.3

24.3

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.3

24.3

221

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

24.2

403

2326

M79.1

ICD-10 Finland

Myalgia

2.3

24.2

249

1177

M05BX04

ATC

denosumab; parenteral

3.0

24.1

145

506

H53.1

ICD-10 Finland

Subjective visual disturbances

2.8

24.1

159

590

4464A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Wegener's granulomatosis

+∞

24.0

M13.0

ICD-10 Finland

Polyarthritis, unspecified

25.8

24.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

23.9

313

1643

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.9

23.9

153

557

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

23.8

352

1938

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

23.7

325

1738

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

242.7

23.7

A01

ICPC

Pain general/multiple sites

2.7

23.7

175

695

R4110

NOMESCO Finland

Physiotherapy

1.8

23.6

521

3304

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

23.9

23.5

TAB00

NOMESCO Finland

Lumbar puncture

3.5

23.5

115

346

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

7.4

23.3

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

23.1

599

3981

M45

ICD-10 Finland

Ankylosing spondylitis

36.7

23.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

22.9

152

565

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

15.7

22.8

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.9

22.8

260

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

84.4

22.7

H57.1

ICD-10 Finland

Ocular pain

4.2

22.6

217

D69.0

ICD-10 Finland

Allergic purpura

11.0

22.6

L15

ICPC

Knee symptom/complaint

2.0

22.4

316

1708

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.9

22.4

254

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.7

22.3

162

634

B01AA03

ATC

warfarin; systemic

1.8

22.3

452

2781

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

22.3

123

405

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

22.0

1195

9616

UDM02

NOMESCO Finland

Sinoscopy

5.0

22.0

145

B02.9

ICD-10 Finland

Zoster without complication

2.8

21.9

145

537

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

21.9

173

712

B01AF01

ATC

rivaroxaban; oral

2.5

21.9

182

771

SPAT1263

SPAT

Sampling

1.6

21.9

799

5823

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

5.0

21.8

146

H65.3

ICD-10 Finland

Chronic mucoid otitis media

6.1

21.8

101

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.7

21.8

E0000UV

ATC

1.6

21.8

722

5124

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

21.6

529

3446

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

11.3

21.4

V03AE02

ATC

sevelamer; oral

16.4

21.4

V03AE01

ATC

polystyrene sulfonate; oral

7.6

21.4

J01FA10

ATC

azithromycin; systemic

1.6

21.3

990

7646

WX892

NOMESCO Finland

Monitored bed care

2.4

21.2

187

818

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

21.1

368

2147

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

21.1

148

568

M09AX01

ATC

hyaluronic acid; parenteral

4.5

21.1

170

L13

ICPC

Hip symptom/complaint

2.1

21.0

269

1396

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

60.7

20.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

20.9

136

500

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

20.7

207

964

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

20.7

278

1473

M48.0

ICD-10 Finland

Spinal stenosis

2.2

20.6

227

1102

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

20.6

520

3411

J05AB11

ATC

valaciclovir; oral

2.0

20.5

275

1455

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.2

20.4

212

1003

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.0

20.4

122

424

M10.0

ICD-10 Finland

Idiopathic gout

6.6

20.3

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

20.2

310

1724

R05

ICD-10 Finland

Cough

1.8

20.2

372

2209

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.9

20.1

222

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

20.0

619

4293

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.3

19.9

104

330

R04.2

ICD-10 Finland

Haemoptysis

3.4

19.8

292

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

19.8

C08CA05

ATC

nifedipine; systemic

2.5

19.8

160

667

J01DA01

ATC

[U] cefalexin; systemic

1.5

19.7

1144

9243

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

106.1

19.6

Z49.2

ICD-10 Finland

Other dialysis

12.3

19.6

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

17.9

19.6

A07AA02

ATC

nystatin; oral

2.6

19.5

143

564

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

19.5

528

3524

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

19.6

19.5

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

21.8

19.5

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

19.4

158

660

H15.1

ICD-10 Finland

Episcleritis

7.6

19.4

M01AX05

ATC

glucosamine; oral

1.9

19.3

326

1873

L90

ICPC

Osteoarthrosis of knee

3.8

19.3

225

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

6.0

19.2

UKC02

NOMESCO Finland

Cystoscopy

1.9

19.2

329

1904

A02BA02

ATC

ranitidine; systemic

1.8

19.2

408

2537

N05CF01

ATC

zopiclone; oral

1.6

19.0

656

4665

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.8

18.9

134

R04.0

ICD-10 Finland

Epistaxis

2.4

18.9

172

764

A03

ICPC

Fever

2.0

18.9

264

1415

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

18.9

160

683

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.9

18.8

210

R60.0

ICD-10 Finland

Localized oedema

2.1

18.8

223

1119

R01AD09

ATC

mometasone; nasal

1.6

18.7

776

5772

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.1

18.7

182

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.3

18.7

110

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

21.0

18.6

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.5

18.5

149

620

205

Kela drug reimbursment

Chronic hypertension

1.6

18.5

591

4119

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

18.4

303

1726

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

18.4

272

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.5

18.3

151

635

JN4AD

NOMESCO Finland

Body CT examination

2.3

18.3

178

815

B05DA

ATC

Isotonic solutions

12.0

18.3

H65.2

ICD-10 Finland

Chronic serous otitis media

6.3

18.1

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

18.0

298

1697

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.3

18.0

106

R01AD08

ATC

fluticasone; nasal

1.7

18.0

497

3324

M01AH02

ATC

rofecoxib; oral

2.0

17.9

240

1265

SPAT1301

SPAT

No procedures

1.6

17.9

618

4378

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.2

17.7

162

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

4.2

17.7

162

L04AC07

ATC

tocilizumab; parenteral

+∞

17.7

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

17.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

17.6

714

5260

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

17.6

266

1469

WZA90

NOMESCO Finland

Other doctors statement

1.8

17.5

373

2308

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.9

17.5

107

378

B03XA01

ATC

erythropoietin; parenteral

8.1

17.5

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

11.6

17.5

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.3

17.5

277

J05AB01

ATC

aciclovir; systemic

1.7

17.5

396

2501

R02

ICPC

Shortness of breath/dyspnoea

2.0

17.5

242

1291

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.6

17.5

131

525

NG2AA

NOMESCO Finland

Patella X-ray examination

10.1

17.4

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

6.7

17.4

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.7

17.4

122

469

318

Kela drug reimbursment

Teriparatide

24.2

17.3

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.4

17.2

264

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.8

17.1

197

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

17.1

129

519

M05BA06

ATC

ibandronic acid; systemic

4.0

17.1

173

NXL00

NOMESCO Finland

Biopsy of muscle

25.8

16.9

B01AX06

ATC

[U] rivaroxaban; oral

22.1

16.9

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

16.8

288

1659

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

16.8

250

1372

J02AC01

ATC

fluconazole; systemic

1.5

16.7

677

4968

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

+∞

16.7

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

16.7

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.8

16.6

106

385

M01CB01

ATC

sodium aurothiomalate; parenteral

90.8

16.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

16.5

293

1710

B01AF02

ATC

apixaban; oral

2.0

16.4

215

1123

M81.4

ICD-10 Finland

Drug-induced osteoporosis

20.2

16.4

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

9.1

16.4

D07AC01

ATC

betamethasone; topical

1.6

16.4

607

4359

JN4BD

NOMESCO Finland

Extensive body CT

1.9

16.3

243

1332

SPAT1255

SPAT

Intravenous administration of medicine

2.4

16.3

138

589

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.8

16.3

115

SPAT1254

SPAT

Administration of medicine

1.8

16.1

296

1743

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

15.9

242

1337

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

15.8

361

2279

A04

ICPC

Weakness/tiredness general

1.9

15.7

256

1450

B05DB

ATC

Hypertonic solutions

13.0

15.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

15.7

186

933

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

15.6

629

4595

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

+∞

15.6

M05.2

ICD-10 Finland

Rheumatoid vasculitis

+∞

15.6

196

Kela drug reimbursment

Paricalcitol and cinacalcet

17.3

15.6

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

15.6

470

3203

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.6

15.6

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.8

15.5

NHQ40

NOMESCO Finland

Amputation of toe

4.6

15.5

121

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

15.5

312

1892

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.7

15.5

184

H26.4

ICD-10 Finland

After-cataract

2.0

15.5

215

1148

M54.5

ICD-10 Finland

Low back pain

1.6

15.4

538

3797

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.3

15.4

136

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.4

15.3

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

15.2

211

1123

WW200

NOMESCO Finland

Immunization

3.5

14.9

201

R51

ICD-10 Finland

Headache

2.8

14.8

370

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.0

14.8

151

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

14.8

584

4241

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

14.8

229

H53.2

ICD-10 Finland

Diplopia

3.2

14.7

246

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

14.7

313

1931

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

14.7

159

766

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

14.7

102

389

5BA08

NOMESCO Finland

9.8

14.7

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

21.2

14.7

H05AA02

ATC

teriparatide; parenteral

21.2

14.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

14.6

253

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

14.6

L04AB01

ATC

etanercept; parenteral

80.7

14.6

R51.81

ICD-10 Finland

Facial pain NOS

4.2

14.6

134

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

14.5

204

1093

R52.9

ICD-10 Finland

Pain, unspecified

2.2

14.5

155

743

R03DC03

ATC

montelukast; oral

1.8

14.5

267

1577

N06AA09

ATC

amitriptyline; systemic

2.0

14.4

193

1014

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

14.4

142

654

RS221

NOMESCO Finland

5.2

14.4

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

15.5

14.4

GD1UN

NOMESCO Finland

Lung circulation SPECT

12.6

14.4

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

14.3

145

678

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

14.3

464

3210

N19

ICD-10 Finland

Unspecified kidney failure

3.0

14.3

285

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

14.3

221

1227

XCK00

NOMESCO Finland

Perimetry

2.1

14.2

156

757

N30.0

ICD-10 Finland

Acute cystitis

1.8

14.2

266

1579

C08CA13

ATC

lercanidipine; oral

1.8

14.1

274

1644

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.2

14.1

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

14.1

121

520

TK820

NOMESCO Finland

Peritoneal dialysis

12.0

14.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

14.1

553

3999

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

14.0

1034

8512

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

13.9

257

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

13.9

376

2481

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

13.8

357

2327

C09CA01

ATC

losartan; oral

1.6

13.8

461

3206

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

13.8

462

3215

R01AD12

ATC

fluticasone furoate; nasal

1.6

13.7

453

3142

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.6

13.7

101

402

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

13.6

446

3089

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.0

13.6

M06

ICD-10 Finland

Other rheumatoid arthritis

+∞

13.6

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

13.5

225

1281

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

13.4

202

G47.3

ICD-10 Finland

Sleep apnoea

1.7

13.4

336

2172

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

18.3

13.4

J01FA09

ATC

clarithromycin; systemic

1.5

13.3

530

3837

M01AH05

ATC

etoricoxib; oral

1.4

13.3

883

7096

L95.8

ICD-10 Finland

Other vasculitis limited to skin

13.9

13.2

GD2SN

NOMESCO Finland

Lung ventilation SPECT

10.5

13.2

R05

ICPC

Cough

1.6

13.2

381

2552

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

13.2

201

1109

M01AH03

ATC

valdecoxib; oral

2.4

13.2

116

508

M13.8

ICD-10 Finland

Other specified arthritis

12.2

13.1

B01AC04

ATC

clopidogrel; oral

1.7

13.1

321

2057

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

15.1

13.1

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.9

13.1

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

13.0

1169

9917

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.4

13.0

185

L99

ICPC

Musculoskeletal disease other

4.8

13.0

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

11.0

13.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

12.9

241

1426

3AC01

NOMESCO Finland

5.9

12.9

K02.1

ICD-10 Finland

Caries of dentine

1.4

12.8

903

7323

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

10.5

12.7

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

7.5

12.7

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.0

12.6

128

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

12.6

146

723

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

12.6

218

1259

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.8

12.5

144

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

12.5

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

+∞

12.5

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

17.4

12.5

N25.0

ICD-10 Finland

Renal osteodystrophy

17.4

12.5

1CX01

NOMESCO Finland

24.5

12.5

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

20.2

12.5

H15.0

ICD-10 Finland

Scleritis

20.2

12.5

C09AA02

ATC

enalapril; systemic

1.6

12.5

401

2756

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

13.2

12.4

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

12.4

400

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

5.4

12.4

L95

ICPC

Osteoporosis

2.8

12.3

278

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

12.3

326

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.2

12.3

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

14.4

12.3

M01AE02

ATC

naproxen; oral, rectal

1.4

12.2

925

7574

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

12.2

152

775

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

12.2

543

4015

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

12.2

299

1917

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

12.2

253

1543

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

12.1

176

955

L40.5

ICD-10 Finland

Arthropathic psoriasis

16.0

12.1

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

12.1

143

716

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

12.1

100

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

12.1

905

7392

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

18.1

12.0

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

12.0

206

1186

EBA10

NOMESCO Finland

Surgical removal of tooth

1.9

11.9

172

930

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

11.9

212

1232

M01AC06

ATC

meloxicam; systemic, rectal

1.5

11.9

582

4385

A28

ICPC

Limited function/disability NOS

1.7

11.9

291

1864

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5.0

11.9

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.4

11.9

167

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

11.9

141

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.7

11.9

136

C08CA02

ATC

felodipine; oral

1.8

11.8

194

1100

E000001

ATC

1.6

11.8

341

2282

L20

ICPC

Joint symptom/complaint NOS

3.1

11.7

201

Z71.8

ICD-10 Finland

Other specified counselling

1.5

11.7

388

2684

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

11.7

135

667

M03BX02

ATC

tizanidine; oral

1.4

11.6

1009

8434

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

11.6

126

609

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

11.6

281

1793

SPAT1262

SPAT

Handing over of treatment supplies

1.6

11.6

336

2249

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

19.0

11.6

R06AE07

ATC

cetirizine; oral

1.4

11.6

710

5579

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

9.3

11.5

SPAT1216

SPAT

Assessment of functional ability

1.6

11.5

293

1896

4AC07

NOMESCO Finland

+∞

11.5

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

+∞

11.5

NGC00

NOMESCO Finland

Exchange of a loose part of prosthesis in knee joint

+∞

11.5

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

11.4

181

1011

R80

ICD-10 Finland

Isolated proteinuria

7.5

11.4

SPAT1310

SPAT

Counselling related to known health issue

1.5

11.4

564

4250

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

11.4

204

1191

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.6

11.3

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

11.3

106

478

R42

ICD-10 Finland

Dizziness and giddiness

1.5

11.3

406

2858

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

11.2

251

1566

L04AB04

ATC

adalimumab; parenteral

9.7

11.2

R52.2

ICD-10 Finland

Other chronic pain

3.0

11.2

208

J01CF05

ATC

flucloxacillin; systemic

2.7

11.1

278

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(42870588) Differential panel, method unspecified - Blood

1421

5595

5.00

318.60

14.0

4.7

—

(3022096) Basophils/100 leukocytes in Blood

1672

7536

5.41

313.26

16.1

4.9

0.6

0.7

4.23

1635

6950

(3019069) Monocytes/100 leukocytes in Blood

1701

7817

5.46

309.59

16.4

5.1

8.5

8.8

3.37

1665

7224

(3019198) Lymphocytes [#/volume] in Blood

1820

8446

6.44

307.65

15.7

4.7

e9/l

1.7

2.0

4.74

1718

7232

(3037522) Nuclear Ab [Titer] in Serum

904

1671

8.25

307.65

1.7

1.2

titre

595.2

424.6

1.70

226

311

(3001604) Monocytes [#/volume] in Blood

1810

8201

6.58

307.65

15.6

4.6

e9/l

0.6

6.85

1696

6878

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

699

456

21.55

307.65

3.9

1.4

titre

338.9

108.0

3.39

108

(3005719) IgG [Mass/volume] in Serum or Plasma

647

1094

7.83

307.65

5.1

2.7

g/l

9.3

10.7

7.85

616

981

(3013115) Eosinophils [#/volume] in Blood

1834

8539

6.57

307.65

16.1

4.9

e9/l

0.2

12.23

1725

7298

(3009445) Proteinase 3 Ab [Units/volume] in Serum

943

594

26.14

307.65

7.3

1.1

u/ml

21.7

10.7

—

255

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

415

356

13.99

307.65

2.1

1.2

g/l

1.2

0.98

396

332

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

407

290

16.82

307.65

1.7

1.6

iu/ml

0.6

0.2

0.41

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

359

220

19.14

307.65

5.9

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

414

345

14.40

307.65

2.1

1.2

g/l

0.2

0.51

393

324

(3006315) Basophils [#/volume] in Blood

1814

8243

6.59

307.65

15.6

4.6

e9/l

0.0

0.01

1698

6922

(3006504) Eosinophils/100 leukocytes in Blood

1688

7775

5.35

304.42

16.2

4.8

2.3

2.9

28.15

1653

7159

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

325

320

11.66

297.10

2.8

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

1686

7881

5.22

294.80

15.7

4.8

62.6

57.5

54.02

1645

7280

(3002030) Lymphocytes/100 leukocytes in Blood

1701

8017

5.25

293.93

16.2

5.0

23.6

27.3

39.75

1663

7372

(3015171) Extractable nuclear Ab [Units/volume] in Serum

345

439

9.06

259.79

1.5

1.1

u/ml

0.3

0.9

0.70

(3028026) IgM [Mass/volume] in Serum or Plasma

475

867

6.64

258.48

2.0

1.9

g/l

1.0

1.4

3.65

442

773

(3013650) Neutrophils [#/volume] in Blood by Automated count

1862

9980

5.46

257.67

18.1

8.3

e9/l

5.0

4.1

34.53

1753

8550

(3004588) Protein electrophoresis panel - Serum or Plasma

537

1127

5.91

252.38

1.6

2.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

588

1412

5.24

236.30

1.8

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1515

7308

4.12

233.15

3.3

2.1

nmol/l

80.8

78.7

2.22

1436

6397

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1746

9464

4.46

222.92

12.8

6.5

mmol/l

1.2

1.65

1534

7893

(3020630) Protein [Mass/volume] in Serum or Plasma

572

1419

5.03

219.95

1.8

3.0

g/l

64.7

66.2

3.85

524

1284

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

192

139

14.97

211.13

2.9

1.1

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

704

2157

4.26

205.06

1.4

1.2

iu/ml

36.1

21.1

2.70

243

569

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

614

1700

4.56

204.61

1.8

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

668

2010

4.27

198.78

1.4

1.2

u/ml

10.1

3.5

1.86

237

737

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1597

8559

3.81

196.90

10.9

5.8

mmol/l

1.2

0.90

1542

7635

(3021879) Hepatitis B virus core Ab [Presence] in Serum

418

867

5.67

196.28

1.4

—

(3023368) Bacteria identified in Blood by Culture

1138

5003

3.51

190.87

5.8

4.0

—

(3017181) Myelocytes/100 leukocytes in Blood

514

1303

4.79

190.52

7.6

3.7

0.9

0.8

0.23

205

406

(40768446) Kidney Pathology biopsy report

129

26.22

185.11

1.4

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

491

1235

4.78

183.31

7.8

3.7

0.1

1.43

194

378

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1325

6523

3.42

182.43

8.7

3.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2000

12854

5.14

180.98

15.3

3.0

mm/h

16.9

12.8

21.36

1946

11563

(3002179) Metamyelocytes/100 leukocytes in Blood

478

1191

4.80

180.38

7.2

3.6

0.5

0.6

0.69

157

287

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

294

8.79

177.81

5.2

iu/ml

428.5

981.5

0.64

(3003458) Phosphate [Moles/volume] in Serum or Plasma

692

2323

3.83

173.83

12.1

5.4

mmol/l

1.1

1.0

3.64

664

2143

(46235355) HIV 1 and 2 tests - Meaningful Use set

639

2044

3.94

172.03

1.9

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

551

1596

4.22

170.31

12.8

7.0

mmol/l

11.3

9.9

4.21

539

1508

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

152

106

15.28

170.23

1.8

1.1

titre

254.9

190.0

0.28

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

329

636

5.87

165.61

1.6

2.0

u/l

33.0

39.2

6.83

302

560

(3036481) Cortisol [Moles/volume] in Serum or Plasma

520

1477

4.25

164.63

2.3

nmol/l

333.5

392.5

6.89

483

1341

(3025159) Blasts/100 leukocytes in Blood

447

1148

4.59

161.31

8.3

3.7

0.0

0.3

0.51

173

315

(3037467) Urinalysis macro (dipstick) panel - Urine

1909

12298

4.18

161.20

10.9

4.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

673

2347

3.64

157.90

4.1

2.5

21.8

22.5

0.69

592

2005

(3022948) Iron [Moles/volume] in Serum or Plasma

735

2714

3.51

157.72

3.9

2.4

umol/l

11.6

12.9

5.90

697

2506

(3024980) IgG subclass 4 [Mass/volume] in Serum

190

211

9.72

157.46

1.7

1.6

g/l

0.7

0.8

0.29

139

169

(3004789) Transferrin [Mass/volume] in Serum or Plasma

696

2518

3.52

153.76

3.9

2.4

g/l

2.2

2.3

7.54

656

2321

(3018418) pH of Serum or Plasma

1149

5604

3.09

152.96

7.7

3.9

7.4

0.26

229

1047

(3018095) Leukocytes [#/volume] in Urine

1242

6354

3.06

151.29

8.8

3.4

e6/l

64.4

139.0

2.83

1010

4466

(3000850) Epithelial cells [#/volume] in Urine

889

3773

3.20

150.56

5.6

2.4

e6/l

4.2

5.9

3.50

820

3281

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1132

5533

3.05

149.14

2.7

2.0

u/l

118.9

245.1

7.08

1077

5168

(3002582) Erythrocytes [#/volume] in Urine

1121

5496

3.02

146.10

7.4

3.0

e6/l

33.0

69.6

3.10

984

4151

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

187

224

9.00

146.04

2.9

2.8

u/ml

67746.9

1625.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

603

2053

3.62

145.52

3.2

4.4

u/l

247.2

244.3

0.17

571

1947

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

216

309

7.61

145.35

1.5

1.1

u/ml

39.1

12.9

0.63

(3035350) Ketones [Presence] in Urine by Test strip

1487

8533

3.08

144.95

7.4

3.5

estimate

0.0

0.00

347

1512

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

186

226

8.86

143.59

1.5

1.1

u/ml

2.0

1.5

0.28

(3009261) Glucose [Presence] in Urine by Test strip

1499

8668

3.08

143.56

7.4

3.5

estimate

0.0

1.08

355

1477

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

205

282

7.88

142.72

1.5

1.1

u/ml

5.6

2.1

1.32

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

206

285

7.84

142.71

1.6

1.1

u/ml

18.6

5.3

1.21

(3021601) Nitrite [Presence] in Urine by Test strip

1482

8547

3.05

142.01

9.8

4.8

estimate

0.0

0.50

359

1513

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

153

145

11.23

141.82

1.4

1.1

—

(3021788) Differential panel - Synovial fluid

118

16.75

139.52

1.6

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

235

388

6.63

138.27

1.7

2.1

mg/l

11.1

12.3

0.80

214

354

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

636

5.27

135.48

1.4

2.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

636

5.27

135.48

1.4

2.8

g/l

3.9

3.7

0.88

220

448

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

637

5.26

135.23

1.4

2.8

g/l

8.4

7.1

15.33

225

468

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

460

1371

3.94

134.29

7.4

3.5

ng/l

114.2

89.5

3.74

434

1154

(3030467) Casts [#/volume] in Urine by Automated count

1031

5043

2.89

131.55

7.3

2.9

e6/l

0.3

0.5

5.90

889

3759

(36304419) Bacteria [Presence] in Urine

1008

4902

2.87

129.58

7.1

2.9

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

137

128

11.31

128.09

1.5

1.3

g/l

2.6

2.8

0.43

(3024139) IgG subclass 3 [Mass/volume] in Serum

137

128

11.31

128.09

1.5

1.3

g/l

0.4

0.94

(3027135) IgG subclass 1 [Mass/volume] in Serum

137

128

11.31

128.09

1.5

1.3

g/l

6.3

7.1

0.87

(3000475) Leukocytes [#/volume] in Synovial fluid

133

119

11.80

127.96

1.7

1.2

e6/l

10017.3

14515.2

0.45

102

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

730

3001

3.09

127.23

2.3

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1998

14148

4.05

126.71

15.7

7.0

u/l

73.6

80.3

11.59

1967

13141

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

281

596

5.23

126.56

1.4

2.8

g/l

9.6

10.5

2.43

242

497

(3024561) Albumin [Mass/volume] in Serum or Plasma

1395

8155

2.79

123.58

8.0

4.6

g/l

33.8

35.1

15.62

1335

7521

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

277

594

5.16

123.09

1.4

2.9

g/l

3.7

3.0

15.69

221

461

(4062490)

135

131

10.88

122.96

1.5

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

574

2087

3.33

122.74

3.5

2.5

1.9

1.8

0.87

531

1837

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

328

814

4.53

122.00

2.2

1.7

g/l

1.9

1.5

7.85

288

690

(3026782) Osmolality of Urine

819

3673

2.91

120.99

5.8

2.6

mosm/kgh2o

513.1

548.3

5.79

732

3088

(3026493) Urate [Moles/volume] in Serum or Plasma

879

4100

2.85

120.50

3.7

2.5

umol/l

2490.2

8083.0

4.59

797

3501

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

240

468

5.61

118.56

1.5

2.7

g/l

0.0

0.1

0.96

220

420

(3021589) Normoblasts [#/volume] in Blood

1330

7718

2.70

117.37

20.8

8.6

e9/l

0.0

0.13

1188

6142

(40760892) CBC W Ordered Manual Differential panel - Blood

767

3375

2.91

116.71

11.3

4.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

19.47

114.83

1.5

1.2

51.8

66.0

1.08

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

254

536

5.20

114.76

1.6

3.9

ratio

1.6

1.7

0.05

(3007164) IgA [Mass/volume] in Serum or Plasma

703

2978

2.96

114.41

1.8

1.5

g/l

2.3

2.5

2.36

526

1731

(3034860) Kappa light chains.free [Mass/volume] in Serum

255

547

5.12

113.01

1.7

3.9

mg/l

49.4

159.4

0.56

199

452

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

255

547

5.12

113.01

1.7

3.9

mg/l

36.5

61.1

1.35

202

454

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

252

540

5.12

111.78

1.7

2.8

g/l

0.2

1.4

5.98

225

457

(3023520) Reticulocytes [#/volume] in Blood

460

1541

3.48

111.28

3.0

2.6

e9/l

70.0

69.8

0.03

330

1145

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

290

712

4.51

108.91

2.2

1.9

ug/l

1.2

1.4

0.24

252

630

(3042936) Bacteria identified in Isolate by Culture

563

2167

3.11

107.98

2.5

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

905

4514

2.65

105.98

2.9

2.1

mg/l

3.2

3.0

1.21

790

3780

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

236

500

5.14

105.94

1.5

2.6

g/l

33.4

38.0

16.01

205

422

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

218

437

5.40

104.17

1.5

2.7

g/l

0.0

0.00

199

398

(3007853) Bacteria identified in Skin by Aerobe culture

515

1928

3.15

103.18

2.4

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

218

444

5.32

102.29

1.5

2.7

g/l

0.0

0.00

199

398

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

532

2083

3.02

98.09

2.1

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1208

7102

2.47

97.43

4.3

2.6

ug/l

177.5

139.9

3.67

1130

6468

(40758558) Short blood count panel - Blood

866

4394

2.55

95.92

12.3

6.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

527

2081

2.99

95.45

2.2

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1733

12122

2.72

94.70

7.7

4.4

e6/l

5229.4

2387.4

0.24

185

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1482

9646

2.50

94.16

6.3

6.5

umol/l

10.1

11.9

7.65

1433

9144

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

280

6.27

93.89

1.6

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

200

407

5.29

93.78

1.6

4.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1600

10831

2.55

92.59

7.2

4.6

mmol/l

6.7

6.8

0.58

1540

10112

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

143

220

6.86

89.45

1.6

1.1

u/ml

62.7

20.4

1.66

(3011397) Hemoglobin [Presence] in Urine by Test strip

801

4061

2.49

87.29

6.9

3.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

175

341

5.47

86.01

1.5

1.3

—

(3037756) Immunofixation for Serum or Plasma

178

356

5.33

84.97

1.3

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

244

632

4.20

84.81

3.0

2.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

658

3086

2.58

84.17

5.9

2.6

e6/l

1.2

0.03

472

1725

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

223

6.52

82.29

1.6

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

112

144

8.12

82.09

1.4

1.2

—

(3011412) CD3 cells [#/volume] in Blood

109

138

8.24

80.91

2.5

2.0

e9/l

1.1

0.20

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

312

1000

3.45

79.41

2.6

2.4

au/ml

36.1

23.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

625

2944

2.54

78.48

2.9

2.1

28.9

29.9

3.15

608

2856

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

129

206

6.57

77.78

1.6

1.4

—

(3032080) INR in Blood by Coagulation assay

1204

7579

2.23

76.37

11.4

9.6

inr

1.2

1.3

1.13

344

2133

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

181

405

4.76

75.66

5.9

3.1

mg/l

1.7

1.5

1.93

171

360

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

134

229

6.15

75.53

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

122

8.43

75.10

1.9

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

136

239

5.98

74.50

1.6

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

285

898

3.48

74.31

1.4

1.3

au/ml

32.7

57.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

26.88

72.71

3.1

1.1

u/ml

13.0

—

(3002032) Base excess in Venous blood by calculation

438

1803

2.76

71.63

7.4

3.4

mmol/l

1.7

2.0

0.94

387

1454

(3021447) Carbon dioxide [Partial pressure] in Venous blood

434

1806

2.73

69.32

7.4

3.3

kpa

5.8

0.07

426

1751

(3037121) Protein [Mass/volume] in Urine

219

606

3.89

69.13

5.5

3.1

g/l

0.4

0.3

1.49

133

250

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

418

4.50

69.10

1.8

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

142

279

5.36

68.97

5.3

3.5

62.1

57.6

2.96

142

279

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

600

2926

2.42

68.67

6.2

2.7

e6/l

3.1

2.7

0.44

410

1578

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

949

5621

2.17

67.88

3.6

3.0

ng/l

1663.9

1519.4

0.44

852

4820

(3030905) Polymorphonuclear cells [#/volume] in Blood

137

268

5.37

66.85

5.1

3.2

e9/l

5.0

4.2

2.60

137

268

(3012516) Albumin [Mass/volume] in Urine

936

5559

2.15

66.04

6.6

3.1

mg/l

373.3

295.2

0.26

699

3393

(3012095) Magnesium [Moles/volume] in Serum or Plasma

611

3051

2.36

65.93

3.7

3.3

mmol/l

0.8

0.10

569

2825

(3000991) Gas panel - Venous blood

385

1546

2.79

65.63

11.6

7.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

134

263

5.35

65.13

1.9

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

214

610

3.76

64.63

2.1

2.2

ug/l

396.1

857.9

0.68

193

577

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

168

404

4.41

64.02

1.9

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

682

3619

2.26

63.39

2.2

1.7

mg/l

1.6

1.3

1.09

556

2743

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

132

263

5.26

63.07

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

950

5762

2.10

62.58

6.8

3.0

mmol/l

6.8

7.2

2.59

842

4783

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

11.73

62.17

1.4

1.3

u/l

5.1

8.3

0.57

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

12.50

61.74

1.1

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

130

264

5.16

60.77

1.7

1.4

u/ml

15.3

11.1

—

(3026008) Bacteria identified in Urine by Culture

964

5932

2.07

60.56

3.9

3.2

—

(3044941) Cell count panel - Synovial fluid

8.70

59.45

1.7

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

253

849

3.22

59.14

8.2

3.7

mmol/l

24.1

24.2

0.12

231

775

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

119

231

5.38

58.50

1.8

1.4

u/ml

115.9

107.9

0.39

(3000494) Fungus identified in Specimen by Culture

434

1950

2.51

58.46

1.8

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

8.51

58.42

2.5

2.1

e6/l

465.4

447.7

0.10

(3020682) Albumin/Creatinine [Ratio] in Urine

948

5870

2.04

57.86

8.1

3.9

mg/mmol

20.4

7.9

7.40

710

3591

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

9.57

57.34

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

9.57

57.34

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

9.57

57.34

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

118

234

5.26

56.64

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

110

7.59

56.55

2.3

1.9

49.7

44.9

0.39

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

120

243

5.15

56.24

1.4

1.3

u/ml

269.3

272.0

0.03

139

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

9.31

56.19

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

9.31

56.19

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

9.31

56.19

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

158

6.30

56.08

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

792

4636

2.08

55.98

8.5

3.8

estimate

0.0

1.08

347

1438

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

8.34

55.28

2.6

2.1

e9/l

0.2

0.58

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

330

1335

2.72

54.88

1.8

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

155

394

4.15

54.81

1.4

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

108

7.44

53.53

2.5

1.8

16.7

15.1

0.19

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

8.36

53.15

2.3

2.2

e6/l

627.8

658.9

0.12

(3017817) Protein [Mass] in Urine collected for unspecified duration

138

6.51

52.68

2.2

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

132

306

4.51

52.59

1.9

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

11.77

51.70

1.5

1.2

32.9

20.3

1.11

(3033658) Prothrombin time (PT) actual/Normal

780

4658

2.02

51.26

5.4

3.8

93.0

88.1

5.69

763

4536

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

7.58

51.01

2.5

1.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2108

17977

2.97

50.78

39.3

13.4

mg/l

22.9

26.0

5.27

2008

13885

(3008757) Leukocyte morphology finding [Identifier] in Blood

181

5.55

49.75

3.0

4.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

157

432

3.83

49.68

1.6

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

247

903

2.94

49.50

1.5

1.2

u/ml

149.2

224.4

1.20

232

829

(3019309) Folate [Moles/volume] in Red Blood Cells

652

3689

2.07

49.44

2.0

1.8

nmol/l

1191.4

1165.8

0.26

520

2759

(3010144) Erythrocytes [#/volume] in Synovial fluid

11.30

49.40

1.5

1.0

e6/l

13180.4

158373.5

0.63

(3015377) Calcium [Moles/volume] in Serum or Plasma

1004

6607

1.92

49.12

3.7

3.6

mmol/l

2.3

2.4

5.14

880

5716

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

112

240

4.85

49.11

1.9

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

153

5.94

48.62

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

892

5664

1.94

48.43

3.0

2.5

u/l

59.0

0.00

838

5196

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1069

7215

1.90

48.08

5.4

3.7

ng/l

41.1

55.2

0.94

848

5223

(40761535) Cells panel - Urine sediment

341

1492

2.51

47.97

8.2

3.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

10.21

46.99

1.2

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1137

7871

1.88

46.84

2.3

2.0

pmol/l

93.0

93.6

0.15

634

3919

(3004809) Band form neutrophils/100 leukocytes in Blood

122

292

4.36

46.64

3.1

3.8

1.1

1.4

0.28

107

223

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

137

358

4.01

46.58

1.3

1.2

mmol/l

3.8

3.9

0.23

125

335

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

149

420

3.72

45.49

1.7

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

146

407

3.76

45.30

1.3

mg/l

468.7

527.6

1.20

137

379

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

22.30

44.67

5.2

3.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1125

7869

1.84

43.83

4.9

3.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

986

6628

1.85

43.64

8.2

3.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

135

5.94

43.29

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

266

1084

2.64

43.14

6.5

3.4

mmol/l

1.4

2.0

2.00

210

795

(3010375) cycloSPORINE [Mass/volume] in Blood

9.02

42.89

25.5

28.0

ug/l

92.8

126.1

2.38

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

273

1131

2.60

42.81

6.6

3.5

kpa

5.1

5.2

0.52

257

1054

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

187

633

3.13

42.74

4.0

3.2

u/ml

0.4

0.05

114

357

(3009343) pH of Capillary blood

270

1118

2.60

42.37

6.6

3.5

7.4

0.10

130

(3022313) Gas panel - Capillary blood

221

827

2.85

42.25

6.6

3.6

—

(40768804) Tissue Pathology biopsy report

1072

7450

1.82

42.10

2.4

2.1

—

(3042733) HLA Ab [Presence] in Serum

12.20

41.98

6.2

3.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

205

4.79

41.29

1.9

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

350

1662

2.30

40.59

9.0

6.6

mmol/l

1.3

1.4

0.73

335

1598

(3017704) Immunofixation for Urine

6.76

40.44

1.3

1.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

136

392

3.62

40.14

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

136

392

3.62

40.14

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

146

446

3.43

39.42

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

13.41

39.15

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

13.41

39.15

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

13.41

39.15

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

13.41

39.15

1.1

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

325

1519

2.33

39.03

6.1

2.8

kpa

5.0

4.5

2.56

315

1471

(3008898) HLA-B27 [Presence]

115

307

3.89

37.92

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

265

1145

2.48

37.88

2.0

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

197

4.66

37.51

1.3

1.2

u/ml

3.6

5.1

0.57

(3044290) Cell count panel - Cerebral spinal fluid

118

324

3.78

37.38

1.3

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

214

4.49

37.35

1.9

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

291

1322

2.37

37.21

3.4

2.6

ml/min/173m2

54.5

64.2

3.68

144

561

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

836

5548

1.79

36.99

3.6

3.2

u/l

31.4

36.5

1.37

802

5238

(3027801) Oxygen [Partial pressure] in Arterial blood

406

2119

2.11

36.98

8.6

7.3

kpa

12.0

12.3

0.44

385

2018

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

406

2120

2.11

36.93

8.6

7.3

kpa

5.0

5.1

2.22

386

2017

(3014576) Chloride [Moles/volume] in Serum or Plasma

442

2383

2.06

36.90

9.5

6.5

mmol/l

103.9

104.3

0.99

433

2327

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

6.00

36.57

1.9

1.5

—

(3023419) Bacteria identified in Sputum by Culture

239

4.24

36.53

2.9

2.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

707

4487

1.83

36.11

1.8

1.5

nmol/l

18.8

20.7

2.94

635

3786

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

9.70

35.98

2.4

2.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

188

703

2.82

35.87

7.1

3.8

mmol/l

24.7

24.8

0.21

177

651

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

178

4.74

35.39

1.6

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

119

342

3.61

35.25

1.4

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

159

4.98

35.25

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

824

5508

1.77

35.15

3.3

2.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

8.78

34.94

1.5

3.9

u/ml

107230.8

37692.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

145

479

3.16

34.45

3.7

2.6

g/l

3.6

0.11

139

450

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

8.61

34.41

1.2

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

141

5.16

33.99

1.3

1.1

u/l

45.1

60.1

2.13

(3041096) Erythrocytes [Presence] in Urine by Automated

707

4563

1.79

33.72

7.1

3.3

—

(44790049)

186

4.53

33.53

1.6

1.3

—

(44790047)

186

4.53

33.53

1.6

1.3

—

(44806118)

186

4.53

33.53

1.6

1.3

—

(44790048)

186

4.53

33.53

1.6

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

24.24

33.42

1.1

1.0

—

(3016502) Oxygen saturation in Arterial blood

360

1866

2.10

33.13

9.2

7.9

96.1

95.4

2.04

345

1803

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

188

4.49

33.09

4.5

4.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

6.38

33.01

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

108

304

3.68

32.99

3.7

3.0

—

(3003396) Base excess in Arterial blood by calculation

395

2128

2.03

32.71

8.8

7.3

mmol/l

1.0

1.1

0.24

319

1658

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

239

4.01

32.32

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

654

4179

1.79

31.96

3.1

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

117

356

3.41

31.75

1.1

—

(3042631) Mycobacterium sp identified in Specimen

256

3.87

31.70

3.3

2.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

12.56

31.53

1.1

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

13.97

31.39

11.3

14.7

mmol/l

5.2

5.8

0.45

(3045414) Leukocytes [Presence] in Urine

182

718

2.67

31.25

2.4

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

318

1607

2.14

31.16

5.3

3.8

mmol/l

1.2

2.22

299

1376

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.89

31.06

2.0

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

7.38

30.99

2.4

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

173

4.51

30.95

1.4

2.4

—

(3036489) Thrombin time

165

622

2.78

30.94

2.4

2.1

22.2

21.8

0.27

153

555

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

165

4.60

30.92

1.7

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

343

1792

2.07

30.76

2.3

2.1

ug/g

211.2

151.2

1.11

290

1382

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

5.91

30.59

1.2

1.1

mg/l

36.8

39.8

0.24

(3019225) pH of Specimen

358

1907

2.04

30.43

8.6

4.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.77

30.41

2.0

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

203

862

2.49

29.92

1.5

1.6

—

(3045424) Erythrocytes [Presence] in Urine

253

3.79

29.85

1.6

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

135

4.93

29.57

1.2

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

114

357

3.31

29.56

1.3

1.4

e6/l

16.5

10.1

0.31

269

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

114

358

3.30

29.42

1.3

1.5

e6/l

1303.3

809.6

0.19

285

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

133

458

3.02

29.40

3.0

2.7

219.1

199.8

1.34

128

436

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

8.08

29.03

2.2

2.6

—

(3052851) Hemolysis interference index of Serum or Plasma

146

536

2.84

28.76

4.3

3.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

8.20

28.65

4.3

2.0

8.1

14.7

1.00

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

5.84

28.07

1.4

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

6.78

28.07

1.3

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

5.70

27.91

1.1

mg/l

252.5

298.2

0.78

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

158

4.47

27.90

1.2

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

146

4.62

27.85

2.0

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

210

3.96

27.83

1.3

1.2

u/ml

14.3

4.3

0.62

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

143

4.65

27.62

2.4

2.5

—

(3000060) B lymphocytes [#/volume] in Blood

10.12

27.41

3.3

1.8

e6/l

108.8

190.8

0.66

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.65

27.13

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

185

4.10

26.71

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

581

3748

1.74

26.71

5.3

3.6

ng/l

179.4

620.0

1.09

488

3043

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

343

1880

1.97

26.67

4.3

3.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

177

4.17

26.58

2.6

3.9

63.3

58.5

0.75

108

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

6.88

25.92

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

118

411

2.97

25.56

1.4

1.2

titre

63.8

63.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

321

1745

1.98

25.50

10.0

8.1

g/l

116.2

120.7

3.63

311

1688

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

575

3740

1.72

25.48

2.8

3.2

mmol/l

2.5

1.75

503

3289

(40768443) Skin Pathology biopsy report

180

778

2.42

25.47

1.3

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

228

1091

2.21

25.45

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

7.30

24.61

2.2

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

163

684

2.49

24.58

2.2

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

246

1234

2.11

24.32

6.3

3.0

g/l

121.9

128.8

4.81

241

1208

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

5.09

24.25

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

118

4.75

24.10

1.3

mmol/l

2.1

0.14

113

(3049717) Cytology report of Urine Cyto stain

169

729

2.42

24.00

2.6

2.7

—

(3002385) Erythrocyte distribution width [Ratio]

1724

14774

1.66

23.83

40.5

16.9

14.3

13.7

40.71

1706

14343

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

5.58

23.69

1.2

1.1

u/l

1.1

0.47

(40768797) Stomach Pathology biopsy report

402

2413

1.81

23.36

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

217

1055

2.17

23.23

3.4

3.1

e9/l

5.0

4.2

3.75

163

798

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

170

747

2.38

23.16

2.5

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1920

16982

1.77

23.06

7.6

5.8

mmol/mol

40.8

40.2

1.29

1824

15361

(3019550) Sodium [Moles/volume] in Serum or Plasma

2102

19137

2.09

23.06

35.2

16.5

mmol/l

139.4

139.7

5.37

2079

18530

(3047007) Chlamydophila sp Ab [Presence] in Serum

183

3.86

22.99

1.2

—

(3028433) Virus identified in Specimen by Culture

6.95

22.93

1.1

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

307

1702

1.93

22.89

2.4

2.3

u/l

33.4

70.3

0.72

267

1456

(3016018) Differential panel - Cerebral spinal fluid

158

4.07

22.67

1.3

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.20

22.65

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

300

1660

1.93

22.48

2.9

2.4

ug/l

5.0

7.6

3.49

247

1446

(3016650) Hepatitis A virus Ab [Presence] in Serum

224

3.52

22.43

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

201

962

2.19

22.36

10.8

9.5

mmol/l

24.4

24.3

0.18

185

904

(3023103) Potassium [Moles/volume] in Serum or Plasma

2103

19192

2.07

22.24

35.9

16.7

mmol/l

4.0

0.26

2075

18545

(4268621)

139

4.25

22.16

2.2

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

144

4.18

22.02

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

194

3.69

21.91

7.6

6.6

mg/l

12.7

12.3

0.29

182

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1215

9707

1.53

21.81

3.1

2.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.15

21.77

1.4

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

11.68

21.36

1.6

1.8

—

(3019060) Gas panel - Arterial blood

238

1241

2.02

21.11

5.0

4.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

6.33

21.02

1.1

ng/l

247.4

615.1

0.37

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

137

4.16

20.84

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

230

3.38

20.84

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.72

20.83

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

11.10

20.67

1.7

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

11.10

20.67

1.7

1.1

88.5

105.5

1.15

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

11.76

20.47

1.1

1.0

—

(3024263) Appearance of Synovial fluid

7.52

20.38

1.8

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

201

999

2.11

20.28

6.1

3.0

mmol/l

25.1

25.2

0.31

196

969

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

188

915

2.15

20.02

5.6

2.3

0.7

0.13

182

883

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1616

13860

1.55

19.97

4.5

4.0

pmol/l

15.2

14.9

4.74

1491

12407

(40761511) CBC panel - Blood by Automated count

2063

18829

1.89

19.92

28.8

13.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

151

3.91

19.86

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

293

1676

1.86

19.70

3.4

2.8

ng/l

215.0

212.6

0.03

267

1537

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2109

19403

2.00

19.67

38.1

16.4

umol/l

95.9

78.3

25.30

2109

19394

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.07

19.52

1.4

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

299

1736

1.83

19.14

2.3

2.1

g/l

0.2

2.71

278

1624

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

131

558

2.43

19.12

1.4

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

254

3.14

19.02

1.2

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

404

2565

1.70

18.94

34.3

26.0

inr

1.3

1.4

0.48

318

(4027681)

5.28

18.92

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

553

3807

1.60

18.79

8.4

3.8

kg/l

1.0

1.34

580

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

148

3.85

18.79

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

148

3.85

18.79

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

148

3.85

18.79

1.6

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

8.35

18.39

1.4

ug/l

0.2

0.4

1.73

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

336

2047

1.75

18.24

2.5

2.8

umol/l

7.1

9.2

1.36

294

1782

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1916

17223

1.66

18.20

29.1

13.2

ml/min/173m2

71.7

77.0

17.81

1757

13949

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1339

11150

1.48

18.12

3.9

3.0

u/l

56.0

51.4

0.70

1268

10194

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.83

18.02

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.83

18.02

1.1

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

105

415

2.60

17.94

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

106

421

2.59

17.94

6.0

4.1

kpa

8.5

0.10

106

411

(3006922) Hepatitis E virus Ab [Presence] in Serum

4.67

17.76

1.1

1.0

—

(3012501) Base excess in Blood by calculation

105

420

2.57

17.51

6.0

4.1

mmol/l

2.5

2.7

0.52

291

(3013290) Carbon dioxide [Partial pressure] in Blood

105

420

2.57

17.51

6.0

4.1

kpa

5.0

0.52

105

411

(3008536) Aspergillus sp Ab [Presence] in Serum

7.81

17.43

1.8

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.42

17.39

1.1

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2102

19448

1.90

17.32

24.4

9.6

u/l

24.3

25.3

1.78

2077

18546

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

4.93

17.10

1.4

1.1

u/l

21.4

17.4

0.27

(1616796) Gas panel - Central venous blood

101

404

2.57

16.86

5.3

3.2

—

(3024471) HLA-A [Type]

6.49

16.65

1.0

—

(3023410) Appearance of Cerebral spinal fluid

166

3.50

16.63

1.5

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

503

3473

1.57

16.62

1.3

1.2

u/ml

0.9

1.8

2.34

124

871

(3025941) Bacteria identified in Stool by Culture

176

900

2.03

16.42

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

367

2361

1.66

16.18

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

4.92

16.16

2.7

37.9

39.4

0.10

(3019174) dRVVT (LA screen)

13.72

15.92

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

4.91

15.69

1.1

1.2

ratio

1.1

0.29

(3024932) HLA-DR beta [Type]

6.25

15.47

1.0

1.1

—

(4306422)

202

3.13

15.15

1.1

1.2

—

(3024928) Oxygen saturation in Venous blood

398

2.47

14.89

5.6

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

392

2.48

14.88

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

121

3.77

14.79

1.4

1.1

—

(3010421) pH of Blood

112

502

2.29

14.60

6.3

3.9

7.4

0.01

105

411

(3003327) Ova and parasites identified in Stool by Light microscopy

109

483

2.32

14.59

1.9

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

7.30

14.40

1.2

2.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

5.56

14.31

1.1

miu/ml

1503.8

1713.0

0.40

(3013512) EKG study

733

5625

1.44

14.15

5.1

4.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.72

14.03

1.7

1.0

—

(3022145) Colonoscopy Study observation

310

1986

1.65

13.77

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

108

489

2.27

13.76

1.3

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1843

16711

1.51

13.72

5.6

4.7

mu/l

1.9

2.1

2.16

1717

15012

(3020891) Body temperature

147

752

2.02

13.70

7.0

4.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

108

492

2.25

13.56

1.3

1.2

—

(3044889) 12 lead EKG panel

1493

13036

1.41

13.43

4.7

3.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

228

2.86

13.42

1.5

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

4.30

13.38

1.1

u/l

24.7

31.7

0.37

(3005988) Vibrio sp identified in Specimen by Organism specific culture

229

2.85

13.31

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

106

485

2.24

13.18

1.3

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

6.95

13.14

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.80

13.07

1.1

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

226

2.84

13.05

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

201

1160

1.80

13.00

9.2

7.0

mmol/l

24.2

24.5

0.48

193

1092

(4010399)

216

1277

1.76

12.87

1.6

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.48

12.84

1.8

7.8

mg/l

123.4

70.2

0.61

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

234

2.78

12.80

1.6

1.4

—

(36660697) Celiac disease serology panel - Serum

209

1226

1.77

12.79

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

8.15

12.76

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

229

2.80

12.74

1.5

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.96

12.72

3.2

3.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

230

2.79

12.64

1.5

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.99

12.59

1.3

1.1

—

(3051651) Icteric interference index of Serum or Plasma

126

3.46

12.49

3.8

4.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

20.14

12.45

2.6

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.66

12.42

1.3

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

8.47

12.37

1.3

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

10.05

12.24

1.6

1.1

44.0

37.6

—

(40761536) Microorganisms panel - Urine sediment

244

1516

1.68

12.15

9.4

3.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

120

3.46

11.94

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

171

964

1.84

11.94

2.5

2.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

448

2.22

11.82

4.9

3.1

mmol/l

24.0

25.3

2.28

400

(40767503) Oxygen content in Capillary blood by calculation

378

2.32

11.78

3.1

2.3

15.9

16.1

0.20

181

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

172

981

1.81

11.57

12.4

10.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

23.00

11.56

1.2

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.69

11.23

2.0

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.69

11.23

2.0

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

10.96

11.06

1.1

1.0

—

(3000492) Spirometry study

231

1458

1.65

10.80

1.7

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.45

10.73

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

17.89

10.72

1.1

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

17.89

10.72

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

216

2.68

10.70

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

105

521

2.06

10.68

1.5

ug/g

287.9

264.2

0.55

309

(3026389) Candida sp identified in Specimen by Organism specific culture

240

2.58

10.63

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

550

4187

1.41

10.56

1.8

1.7

pmol/l

37768712.2

30437773.4

0.12

466

3407

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.54

10.32

1.4

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

2131

20228

1.69

10.30

50.3

20.3

g/l

128.7

134.4

58.75

2114

19796

(3027456) Digoxin [Moles/volume] in Serum or Plasma

454

2.12

10.28

3.4

3.2

nmol/l

0.9

0.8

0.55

343

(3023183) Ammonium ion [Moles/volume] in Plasma

375

2.23

10.27

1.4

2.8

umol/l

26.7

36.0

4.59

315

(3007461) Platelets [#/volume] in Blood

2129

20210

1.68

10.21

50.0

20.1

e9/l

263.9

247.0

23.11

2106

19493

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.59

10.21

1.7

1.5

u/l

4.6

7.7

0.49

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.51

10.17

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.18

10.13

1.1

1.2

—

(3024731) MCV [Entitic volume]

2129

20218

1.68

10.09

49.8

20.1

92.0

91.2

10.02

2113

19777

(3035941) MCH [Entitic mass]

2129

20219

1.68

10.07

49.7

20.0

30.2

30.3

3.25

2113

19779

(3026361) Erythrocytes [#/volume] in Blood

2129

20220

1.68

10.06

50.0

20.1

e12/l

4.3

4.5

39.77

2101

19420

(3010813) Leukocytes [#/volume] in Blood

2129

20225

1.67

9.99

50.1

20.2

e9/l

7.7

6.7

61.92

2103

19430

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.16

9.84

1.1

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.55

9.77

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

294

2.35

9.72

2.4

1.8

mmol/l

1.7

0.00

284

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.90

9.59

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.46

9.55

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

131

731

1.84

9.48

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.48

9.47

1.8

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.48

9.47

1.8

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.48

9.47

1.8

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.48

9.47

1.8

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

6.19

9.46

1.4

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.61

9.35

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

7.04

9.29

1.6

1.5

ng/l

115.0

105.1

0.11

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

127

3.03

9.01

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

207

2.55

8.90

4.2

3.7

—

(3029075) Extractable nuclear Ab panel - Serum

5.18

8.88

1.1

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.35

8.87

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.50

8.83

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.37

8.76

4.9

3.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

124

3.02

8.74

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

209

2.52

8.73

1.5

1.3

mu/l

200.1

45.7

0.76

190

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.48

8.65

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.48

8.65

1.4

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

10.04

8.64

1.7

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

10.04

8.64

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.41

8.61

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1845

17140

1.38

8.58

4.8

4.0

mmol/l

1.3

3.02

1704

15297

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.10

8.26

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

129

2.90

8.18

1.1

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.03

8.07

2.5

1.7

ug/l

77.3

60.3

0.40

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

120

2.95

7.97

1.5

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1912

17937

1.38

7.79

5.3

4.5

mmol/l

4.6

2.08

1779

16266

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.55

7.69

2.0

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.55

7.69

2.0

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.55

7.69

2.0

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

158

988

1.64

7.69

2.9

3.4

pmol/l

4.3

4.5

1.23

136

866

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.35

7.68

1.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

103

572

1.84

7.62

5.9

3.8

mmol/l

4.0

3.9

0.88

532

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1895

17785

1.36

7.43

5.3

4.4

mmol/l

1.5

4.77

1757

16017

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.92

7.43

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.03

7.34

1.5

1.2

—

(3047185) IgG [Mass/volume] in Urine

+∞

7.29

1.0

0.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.24

7.25

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

327

2.08

7.22

1.5

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

20.08

7.13

2.0

3.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.78

7.08

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

380

1.98

6.96

2.7

2.1

g/l

125.8

128.7

0.49

278

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

177

2.46

6.94

4.7

2.7

—

(3047189) Immunofixation for 24 hour Urine

3.07

6.89

1.2

1.6

—

(4035726)

250

1775

1.46

6.87

1.3

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.44

6.77

1.2

1.1

—

(3045716) Anion gap in Serum or Plasma

3.23

6.70

3.8

2.6

mmol/l

8.5

9.3

0.47

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

206

2.31

6.62

2.8

1.8

mg/l

26.9

19.3

0.50

(3021901) Oxygen saturation in Capillary blood

340

2.00

6.53

3.4

2.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1942

18385

1.35

6.48

5.8

5.0

mmol/l

2.6

2.7

9.08

1811

16604

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.85

6.45

1.3

2.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

3.15

6.44

1.6

3.3

105.3

93.8

0.78

(3050794) Legionella sp Ab [Presence] in Serum

6.69

6.31

1.0

1.1

—

(3025315) Body weight

6.69

6.31

5.3

4.8

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.48

6.29

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.48

6.29

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.48

6.29

1.3

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

18.06

6.26

1.8

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.85

6.26

1.1

—

(3017569) Oxygen content in Arterial blood

3.14

6.16

1.5

2.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

594

4905

1.28

6.15

1.8

1.6

mmol/l

1.4

1.3

0.48

510

4055

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.55

6.08

4.7

4.4

—

(3016038) Potassium [Moles/volume] in Urine

123

2.62

5.97

1.2

mmol/l

31.5

35.8

0.56

106

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

191

2.28

5.91

1.2

1.3

pmol/l

536.5

299.7

1.10

143

(3001686) Cold agglutinin [Titer] in Serum or Plasma

4.40

5.76

1.3

1.2

—

243.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1890

17898

1.31

5.72

5.9

4.7

mmol/l

5.9

6.0

2.26

1752

16004

(4015189)

3.72

5.64

1.5

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

1734

16251

1.27

5.64

35.2

15.1

37.7

39.0

5.81

1118

10950

(3034426) Prothrombin time (PT)

3.55

5.60

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

12.90

5.58

3.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

223

2.13

5.53

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

420

1.81

5.50

1.5

1.9

iu/l

4.8

0.00

145

(3036603) Volume of Urine

124

2.52

5.37

1.4

2284.0

1770.5

—

(3009871) Measles virus Ab [Titer] in Serum

4.14

5.36

1.6

—

(3003181) Sodium [Moles/volume] in Urine

354

1.86

5.22

1.7

1.3

mmol/l

52.8

60.7

1.39

279

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

+∞

5.21

1.2

0.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.65

5.20

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

307

2369

1.34

5.16

5.0

4.6

33.1

33.3

0.10

249

1488

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

121

2.50

5.12

1.6

1.3

u/ml

1.0

1.3

0.12

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.77

5.09

1.7

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

122

796

1.56

5.06

5.7

5.5

0.9

0.05

114

754

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

426

1.76

4.98

1.1

u/ml

0.8

8.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

122

803

1.55

4.88

5.8

5.4

1.5

1.6

0.09

114

758

(3046861) Legionella sp Ag [Presence] in Urine

11.46

4.78

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.59

4.76

1.1

—

(21494755) Public health laboratory ask at order entry panel

1139

0.58

4.63

1.2

1.4

—

(21494434) Karyotype in Bone marrow

172

2.17

4.63

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

399

1.75

4.60

3.2

2.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.84

4.53

1.2

1.3

nmol/l

203.9

144.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.56

4.30

1.2

—

(3011648) Oxygen content in Venous blood

145

2.22

4.28

5.7

1.8

10.2

11.0

0.60

145

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.36

4.09

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.76

4.08

1.7

1.0

—

(3048879) Bone marrow aspiration report

3.09

4.08

1.8

1.4

—

(3003694) ABO and Rh group [Type] in Blood

550

4694

1.23

4.06

1.5

1.3

—

(3000012) Reticulocyte production index

2.44

3.97

1.8

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.54

3.96

1.5

2.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

457

1.64

3.93

2.5

2.3

ug/min

311.9

101.3

1.23

284

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.65

3.92

1.3

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

220

1.93

3.87

1.3

nmol/l

—

(3022621) pH of Urine by Test strip

165

1212

1.39

3.82

4.4

3.0

—

(3019977) pH of Arterial blood

101

2.39

3.81

4.0

2.9

7.4

—

(3047181) Lactate [Moles/volume] in Blood

564

1.56

3.79

6.6

6.8

mmol/l

1.2

1.3

0.30

497

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

3.20

3.77

1.1

106.4

96.2

0.59

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.20

3.77

1.1

1.4

114.0

81.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.54

3.76

1.2

1.3

mmol/l

1.2

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

12.03

3.76

1.2

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

230

1.89

3.74

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

141

2.14

3.71

1.6

1.5

u/ml

17.5

18.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.62

3.64

1.5

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

345

1.70

3.57

1.3

1.2

miu/ml

183.3

223.7

0.35

152

(44806071)

6.17

3.50

1.3

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

10.02

3.50

1.0

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1238

0.66

3.49

1.5

1.7

—

(1761868) Lipid panel - Serum or Plasma

510

5891

0.83

3.48

3.2

3.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.55

3.46

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.99

3.41

11.5

8.5

—

(40757373) Influenza virus identified in Isolate

2.99

3.41

1.7

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.11

3.37

1.7

2.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.73

3.34

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

205

1.87

3.26

1.3

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

122

2.14

3.26

1.7

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

147

1093

1.37

3.20

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.97

3.13

1.2

1.1

91.2

79.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

687

0.57

3.09

2.0

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

810

0.61

3.08

1.3

1.4

—

(3002619) Bacteria identified in Specimen by Culture

3.25

3.06

1.0

1.1

—

(4094501)

482

1.53

3.00

1.1

—

(3004451) EKG impression Narrative

100

2.21

2.99

1.7

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.30

2.99

1.7

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

10.02

2.98

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.10

2.88

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.40

2.87

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.40

2.87

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.30

2.84

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

291

1.66

2.82

2.0

2.1

u/l

8611.5

2719.6

0.38

120

(3000330) Specific gravity of Urine by Test strip

136

1023

1.35

2.79

6.5

3.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.01

2.73

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

628

1.43

2.67

1.7

1.6

—

(3004775) Volume in Urine collected for unspecified duration

147

1.92

2.65

2.4

2.3

985.8

569.4

3.85

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.01

2.56

1.4

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.15

2.55

1.8

1.4

—

(3018572) Chloride [Moles/volume] in Blood

412

1.52

2.52

7.6

7.8

mmol/l

104.9

105.1

0.17

373

(3039000) Anion gap in Blood

412

1.52

2.52

7.6

7.8

mmol/l

11.8

11.1

1.17

373

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.04

2.52

1.5

1.8

ug/l

7.9

9.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

122

1.98

2.50

3.7

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

288

2417

1.22

2.49

13.5

6.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.47

2.45

3.1

2.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

272

1.63

2.44

1.7

1.4

e6/l

1574.2

1673.2

0.09

197

(3036525) Urea [Moles/time] in 24 hour Urine

6.26

2.37

2.2

3.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

322

1.57

2.36

1.4

u/l

13.6

11.1

0.43

260

(40768806) Pleura Pathology biopsy report

236

1.66

2.36

1.7

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.87

2.30

1.1

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

137

1065

1.30

2.29

1.2

iu/ml

169.6

141.5

0.28

396

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.38

2.29

5.6

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.38

2.29

5.6

2.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.46

2.27

2.9

2.2

ug/l

31.5

17.1

0.61

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.62

2.27

1.2

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

640

5786

1.15

2.26

4.8

5.2

ug/l

3.9

3.1

0.23

556

5130

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.03

2.26

4.3

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.42

2.19

1.8

2.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

180

1.73

2.19

1.5

1.3

—

(3005570) Glucose [Moles/volume] in Urine

188

1.71

2.17

1.5

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

478

1.44

2.14

1.3

1.4

iu/l

28.8

31.3

0.28

406

(3006462) Nitrate [Presence] in Urine

2.11

2.12

6.8

2.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.57

2.09

10.2

9.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.57

2.09

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.01

2.07

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.01

2.07

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.51

2.05

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.01

2.04

1.5

1.7

—

(3012441) Differential panel - Pleural fluid

223

1.62

2.03

1.7

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.64

2.01

2.2

3.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

286

0.49

2.01

1.6

—

(3002256) Pathology report gross observation

290

2489

1.19

2.00

1.4

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

249

1.58

1.95

1.6

1.4

e6/l

37432.6

68510.1

0.39

148

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

263

2246

1.19

1.93

2.7

4.3

ug/l

7.7

25.4

2.57

211

1853

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.19

1.88

1.0

—

(3045788) Cell count panel - Pleural fluid

213

1.61

1.85

1.7

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.40

1.85

2.2

1.7

pmol/l

16.8

14.4

0.71

(4211845)

1.98

1.85

6.8

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

3.54

1.84

4.7

7.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.54

1.84

2.3

3.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

101

1.89

1.80

2.4

1.2

nmol/l

1.2

0.11

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.05

1.80

1.0

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.05

1.80

1.4

1.6

umol/l

41.3

35.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.17

1.77

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.34

1.74

1.0

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

381

1.43

1.72

1.8

1.6

mu/l

381.1

306.1

0.44

353

(3008295) Osmolality of Serum or Plasma

186

1.62

1.72

1.6

1.5

mosm/kgh2o

277.3

279.0

0.13

136

(3025549) Creatine [Moles/time] in 24 hour Urine

3.85

1.71

1.8

—

(3022689) Creatine [Moles/volume] in Urine

2.39

1.67

2.9

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

597

0.68

1.67

2.1

1.7

mg/l

12.9

4.1

0.77

418

(4281824)

227

0.48

1.66

1.4

1.2

—

(3014271) Vancomycin [Susceptibility]

1.86

1.66

3.3

3.0

—

(4198724)

2.33

1.60

1.4

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

215

1.54

1.57

1.1

u/ml

1.5

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.07

1.49

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

178

1.58

1.48

1.3

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.13

1.44

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

127

1047

1.23

1.40

1.6

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

121

1.66

1.30

2.0

2.3

umol/l

9.2

9.4

0.03

(3020393) Adenovirus Ag [Presence] in Stool

2.78

1.28

1.4

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

218

0.55

1.28

1.3

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

261

1.42

1.25

1.1

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.63

1.21

2.0

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.73

1.15

2.5

2.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

501

1.29

1.14

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

1.14

0.0

1.7

—

(4133840)

2.34

1.12

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

2.26

1.10

1.1

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.19

1.08

7.3

8.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

502

4668

1.10

1.06

4.1

4.5

21.3

22.1

0.57

252

2380

(3023511) Choriogonadotropin [Units/volume] in Urine

145

1.52

1.06

1.5

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

280

1.36

1.04

4.7

2.3

—

(4212803)

2.28

1.03

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.74

1.02

1.1

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

111

941

1.19

0.99

1.6

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.84

0.98

1.1

1.0

—

(4024509)

181

1.44

0.98

1.5

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.18

0.98

2.0

2.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.89

0.94

1.0

2.2

—

(3000285) Sodium [Moles/volume] in Blood

2.23

0.93

1.2

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

572

1.23

0.92

5.6

4.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.15

0.91

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

1.53

0.90

1.4

1.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

160

1.44

0.89

1.1

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

126

1096

1.16

0.85

2.0

2.1

nmol/l

12.9

0.03

104

962

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

373

1.27

0.81

2.4

1.5

nmol/l

0.9

0.8

0.54

305

(44813793)

1.58

0.81

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

198

1.37

0.80

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

198

1.37

0.80

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

474

1.23

0.79

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

123

1.47

0.77

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.70

0.75

1.8

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.09

0.74

2.0

2.2

—

(37021550) Renin [Units/volume] in Plasma --upright

1.80

0.72

1.0

1.3

mu/l

57.3

59.3

—

(3015183) Erythrocyte sedimentation rate

1.67

0.72

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.75

0.71

1.3

1.6

—

(40765096) Chromosome analysis panel by Banding

1.55

0.69

1.2

—

(3035880) pH of Pleural fluid

112

1.43

0.63

1.8

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

138

1.38

0.62

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

199

0.70

0.61

1.6

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.60

0.61

1.8

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

253

1.27

0.61

3.6

4.9

umol/l

291.4

370.0

1.68

223

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

3.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

487

0.82

0.59

1.8

1.7

—

(3011288) Drugs identified in Urine by Screen method

242

0.74

0.58

2.2

2.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.58

0.54

1.0

1.1

—

6.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

188

1733

1.09

0.54

1.5

1.8

1.7

1.5

1.84

162

1505

(3052592) Norovirus Ag [Presence] in Stool

1.54

0.53

1.0

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

143

1.33

0.52

1.0

ng/l

42.8

46.8

0.17

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

143

1.33

0.52

1.0

ng/l

661.4

669.4

0.04

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

157

0.70

0.51

1.3

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

194

1797

1.09

0.51

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

191

0.73

0.50

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

191

0.73

0.50

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

101

1.39

0.49

1.1

1.4

g/l

0.7

1.0

3.00

101

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

190

0.74

0.49

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

190

0.74

0.49

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

110

0.64

0.48

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

352

3345

1.06

0.47

3.0

3.1

ug/l

0.7

0.8

3.93

266

2271

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

245

1.23

0.47

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

165

1.28

0.45

6.1

2.8

mg/l

84.4

14.8

0.94

123

(4146454)

212

1.23

0.42

3.0

2.7

—

(40768793) Breast Pathology biopsy report

499

0.86

0.42

1.4

1.3

—

(40768800) Prostate Pathology biopsy report

381

0.84

0.42

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.40

0.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

182

0.77

0.39

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

142

1.27

0.38

1.0

ng/l

331.8

325.8

0.03

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

810

1.10

0.37

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

134

0.75

0.35

1.3

1.5

—

(3020650) Glucose [Presence] in Urine

1.33

0.33

2.2

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

268

1.16

0.30

1.1

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.33

0.30

6.5

3.5

u/l

225.8

206.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

526

1.11

0.28

1.6

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

243

2531

0.96

0.26

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

331

0.87

0.26

1.5

—

(44806420)

0.67

0.26

2.0

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

160

0.81

0.26

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

1.17

0.24

1.1

1.2

nmol/l

182.8

140.4

—

(1002224) Polysomnography panel

554

1.09

0.22

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

157

0.83

0.22

1.3

1.4

—

(3003338) MCHC [Mass/volume]

1524

15112

1.02

0.22

45.5

18.0

g/l

328.1

332.0

49.60

1513

14963

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.19

0.21

1.0

1.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.6

—

(3020491) Glucose [Moles/volume] in Blood

135

1.19

0.21

1.9

1.8

mmol/l

6.8

6.7

0.11

(3016879) Cocaine [Presence] in Urine

315

1.11

0.21

1.5

2.1

—

(3025130) Human papilloma virus identified in Specimen

182

1.16

0.21

1.6

1.8

—

(3005033) Fetal Nuchal fold Thickness US

156

0.83

0.21

1.3

1.4

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

4.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.25

0.20

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

782

1.06

0.19

3.0

3.5

u/ml

60.5

6081.6

1.03

674

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

100

1.20

0.18

5.3

6.5

—

(4034850)

631

0.93

0.18

26.4

9.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

142

0.84

0.17

1.0

u/ml

0.8

2.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

254

1.10

0.16

2.6

2.3

u/ml

3.4

1723.7

0.85

244

(1001926) Buprenorphine [Presence] in Urine by Screen method

265

1.10

0.14

1.6

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

383

1.07

0.13

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

211

1.09

0.11

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

182

1.10

0.11

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

218

0.92

0.10

1.0

1.1

u/ml

0.5

1.6

—

(3027944) Amphetamines [Presence] in Urine

330

1.06

0.09

1.7

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.11

0.09

1.0

1.4

—

(3033799) Differential panel - Peritoneal fluid

0.81

0.08

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.05

0.07

1.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

159

1.07

0.05

1.9

2.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

413

0.97

0.04

1.4

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

338

1.04

0.04

1.6

2.1

—

(3028300) Cannabinoids [Presence] in Urine

339

1.03

0.03

1.7

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

451

0.98

0.03

8.7

3.5

mg/l

34.0

28.8

0.43

290

(3003888) Timothy IgE Ab [Units/volume] in Serum

189

0.95

0.03

1.0

1.1

u/ml

1.5

5.4

—

(3051593) INR in Capillary blood by Coagulation assay

108

0.93

0.03

4.6

19.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

108

0.93

0.03

1.2

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

123

1222

1.01

0.01

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

119

1.01

0.00

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

181

0.99

0.00

1.7

2.1

u/field

0.5

2.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

128

1.02

0.00

2.5

1.6

—

(3027008) Opiates [Presence] in Urine

338

1.01

0.00

1.6

2.1

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

321.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.1

—

(4038314)

0.00

0.0

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.2

—

79.0

—

(40768441) Liver Pathology biopsy report

120

1.00

0.00

1.5

1.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.85

0.00

1.6

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.90

0.00

1.0

1.1

—

5.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.5

—

2.7

—

(3044007) Cell count panel - Peritoneal fluid

0.98

0.00

2.8

2.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

13.8

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint NECROVASC_FG and mortality.

Females

Parameter	HR [95% CI]	p-value
NECROVASC_FG	1.505 [1.37, 1.65]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.346

During the follow-up period (1.1.1998 — 31.12.2019), 2254 out of 6574 females with NECROVASC_FG died.

Males

Parameter	HR [95% CI]	p-value
NECROVASC_FG	1.727 [1.51, 1.97]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 1461 out of 3883 males with NECROVASC_FG died.

Mortality risk

Mortality risk for people of age

years, who have NECROVASC_FG.

N-year risk	Females	Males
1	0.134%	0.259%
5	0.835%	1.848%
10	1.974%	5.055%
15	4.086%	9.363%
20	7.268%	15.733%

Relationships between endpoints

↥

Index endpoint: NECROVASC_FG – Other necrotizing vasculopathies (FG)

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other necrotizing vasculopathies (FG)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints